Officials at Novo Nordisk have announced that an oral tablet version of the GLP-1 drug became available on May 4 for adults diagnosed with type 2 diabetes
6 Reuters Novo again raises its bid
In particular, CuAAC (Figure 4B) and SPAAC (Figure 4C) focus on the functionalization with azide and alkyne groups to link molecules such as proteins, peptides, carbohydrates, and fatty acids to other biomolecules or polymer matrices for generating biohybrid scaffolds with a plethora of improved properties
But used wisely, with resistance training, protein optimisation, and patient selection, they may represent the most significant advance in cardiometabolic medicine since statins
The gastroparesis that has prompted many Ozempic and Mounjaro patients to file lawsuits stems from these drugs, causing it to take too long for their stomachs to empty out